Peptides: Why FDA’s Stance is Putting Patients at Risk
As the FDA tightens its grip on peptides, a murky and inconsistent regulatory framework that’s not fit-for-purpose is putting patient access at risk. Action Alert! THE TOPLINE Peptide bioregulators are very short chains of amino acids—the same building blocks that make proteins—that are linked by peptide bonds that act as precision signals in the body. […]










